Interaction of Laponite with Membrane Components-Consequences for Bacterial Aggregation and Infection Confinement.

The antimicrobial effects of Laponite nanoparticles with or without loading of the antimicrobial peptide LL-37 was investigated along with their membrane interactions. The study combines data from ellipsometry, circular dichroism, fluorescence spectroscopy, particle size/ζ potential measurements, and confocal microscopy. As a result of the net negative charge of Laponite, loading of net positively charged LL-37 increases with increasing pH. The peptide was found to bind primarily to the outer surface of the Laponite nanoparticles in a predominantly helical conformation, leading to charge reversal. Despite their net positive charge, peptide-loaded Laponite nanoparticles did not kill Gram-negative Escherichia coli bacteria or disrupt anionic model liposomes. They did however cause bacteria flocculation, originating from the interaction of Laponite and bacterial lipopolysaccharide (LPS). Free LL-37, in contrast, is potently antimicrobial through membrane disruption but does not induce bacterial aggregation in the concentration range investigated. Through LL-37 loading of Laponite nanoparticles, the combined effects of bacterial flocculation and membrane lysis are observed. However, bacteria aggregation seems to be limited to Gram-negative bacteria as Laponite did not cause flocculation of Gram-positive Bacillus subtilis bacteria nor did it bind to lipoteichoic acid from bacterial envelopes. Taken together, the present investigation reports several novel phenomena by demonstrating that nanoparticle charge does not invariably control membrane destabilization and by identifying the ability of anionic Laponite nanoparticles to effectively flocculate Gram-negative bacteria through LPS binding. As demonstrated in cell experiments, such aggregation results in diminished LPS-induced cell activation, thus outlining a promising approach for confinement of infection and inflammation caused by such pathogens.

[1]  J. Lu,et al.  Membrane targeting cationic antimicrobial peptides. , 2019, Journal of colloid and interface science.

[2]  Oliver C. J. Andrén,et al.  Membrane interactions of microgels as carriers of antimicrobial peptides. , 2018, Journal of colloid and interface science.

[3]  M. Malmsten,et al.  Membrane interactions and antimicrobial effects of inorganic nanoparticles. , 2017, Advances in colloid and interface science.

[4]  A. Schmidtchen,et al.  Membrane interactions and antimicrobial effects of layered double hydroxide nanoparticles. , 2017, Physical chemistry chemical physics : PCCP.

[5]  Yue Zhang,et al.  Nanoparticle-based local antimicrobial drug delivery. , 2017, Advanced drug delivery reviews.

[6]  Roland G. Huber,et al.  Aggregation of thrombin-derived C-terminal fragments as a previously undisclosed host defense mechanism , 2017, Proceedings of the National Academy of Sciences.

[7]  Martin Malmsten,et al.  Delivery systems for antimicrobial peptides. , 2017, Advances in colloid and interface science.

[8]  M. Skepö,et al.  Flocculated Laponite-PEG/PEO Dispersions with Multivalent Salt: A SAXS, Cryo-TEM, and Computer Simulation Study , 2017 .

[9]  J. Mayoral,et al.  Laponite as carrier for controlled in vitro delivery of dexamethasone in vitreous humor models. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  A. Schmidtchen,et al.  Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides. , 2016, Journal of colloid and interface science.

[11]  A. Schmidtchen,et al.  Pseudomonas aeruginosa elastase cleaves a C-terminal peptide from human thrombin that inhibits host inflammatory responses , 2016, Nature Communications.

[12]  Erin E. Gill,et al.  The immunology of host defence peptides: beyond antimicrobial activity , 2016, Nature Reviews Immunology.

[13]  R. Tilton,et al.  Inhibition of bacterial surface colonization by immobilized silver nanoparticles depends critically on the planktonic bacterial concentration. , 2016, Journal of colloid and interface science.

[14]  Xiangyang Shi,et al.  Fine tuning of the pH-sensitivity of laponite-doxorubicin nanohybrids by polyelectrolyte multilayer coating. , 2016, Materials science & engineering. C, Materials for biological applications.

[15]  J. M. Lanao,et al.  Current applications of nanoparticles in infectious diseases. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[16]  C. Boyer,et al.  Iron oxide nanoparticle-mediated hyperthermia stimulates dispersal in bacterial biofilms and enhances antibiotic efficacy , 2015, Scientific Reports.

[17]  Wenjuan Jiang,et al.  Simulating Gram-Negative Bacterial Outer Membrane: A Coarse Grain Model. , 2015, The journal of physical chemistry. B.

[18]  V. A. Dhumale,et al.  Antimicrobial potential of TiO2 nanoparticles against MDR Pseudomonas aeruginosa , 2015 .

[19]  João Rodrigues,et al.  Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery. , 2014, ACS applied materials & interfaces.

[20]  Chih-Wei Chiu,et al.  Intercalation strategies in clay/polymer hybrids , 2014 .

[21]  A. Schmidtchen,et al.  Importance of lipopolysaccharide aggregate disruption for the anti-endotoxic effects of heparin cofactor II peptides. , 2013, Biochimica et biophysica acta.

[22]  W. Chrzanowski,et al.  Laponite clay as a carrier for in situ delivery of tetracycline , 2013 .

[23]  Mingwu Shen,et al.  Laponite nanodisks as an efficient platform for Doxorubicin delivery to cancer cells. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[24]  P. Bartlett,et al.  Reduction in the size of layered double hydroxide nanoparticles enhances the efficiency of siRNA delivery. , 2013, Journal of colloid and interface science.

[25]  S. Gilchrist,et al.  The application of layered double hydroxide clay (LDH)-poly(lactide-co-glycolic acid) (PLGA) film composites for the controlled release of antibiotics , 2012, Journal of Materials Science: Materials in Medicine.

[26]  Young Jik Kwon,et al.  "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[27]  A. Coates,et al.  Novel classes of antibiotics or more of the same? , 2011, British journal of pharmacology.

[28]  Y. B. Choy,et al.  Controlled release of donepezil intercalated in smectite clays. , 2008, International journal of pharmaceutics.

[29]  C. Caramella,et al.  Use of clays as drug delivery systems: Possibilities and limitations , 2007 .

[30]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[31]  A. Schmidtchen,et al.  Effect of peptide length on the interaction between consensus peptides and DOPC/DOPA bilayers. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[32]  S. Ulvenlund,et al.  Comparison of the helix-coil transition of a titrating polypeptide in aqueous solutions and at the air-water interface. , 2005, Biophysical chemistry.

[33]  Fredrik Carlsson,et al.  Lysozyme adsorption to charged surfaces : A Monte Carlo Study , 2004 .

[34]  H. Nikaido Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.

[35]  K. Brandenburg,et al.  Physicochemical properties of bacterial glycopolymers in relation to bioactivity. , 2003, Carbohydrate research.

[36]  Jiang-Jen Lin,et al.  Critical Conformational Change of Poly(oxypropylene)diamines in Layered Aluminosilicate Confinement , 2003 .

[37]  T. Hartung,et al.  Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. , 2001 .

[38]  C. Muzny,et al.  Surfactant Adsorption on a Clay Mineral: Application of Radiation Scattering , 1997 .

[39]  W. Fischer Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus , 1994, Medical Microbiology and Immunology.

[40]  M. Roberts,et al.  Formulation and antibacterial profiles of clay–ciprofloxacin composites , 2014 .